The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Polatuzumab vedotin + obinutuzumab + venetoclax in patients with relapsed/refractory (R/R) follicular lymphoma (FL): Primary analysis of a phase 1b/2 trial.
 
Rajat Bannerji
Employment - Sanofi Pasteur (I)
Research Funding - Abbvie (Inst); Abbvie/Pharmacyclics (Inst); Genentech (Inst); Regeneron (Inst); Roche (Inst)
 
Sam Yuen
Honoraria - Lymphoma & Myeloma Connect
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Bayer; Bristol-Myers Squibb; Genentech; Incyte; Pharmacyclics; TG Therapeutics
Research Funding - Abbvie; Bayer; Bristol-Myers Squibb; Incyte
 
Tycel Jovelle Phillips
Honoraria - Bayer; Genentech; Gilead Sciences; Incyte; Pharmacyclics; Seagen
Consulting or Advisory Role - Bayer; Celgene; Curis; Genentech; Gilead Sciences; Gilead Sciences; Incyte; Kite/Gilead; Pharmacyclics; Seagen
Speakers' Bureau - Genmab
Research Funding - Abbvie; Bayer; Pharmacyclics/Janssen
 
Christopher Arthur
No Relationships to Disclose
 
Iris Isufi
Consulting or Advisory Role - AstraZeneca; Celgene/Jazz; Kite, a Gilead company
Travel, Accommodations, Expenses - Celgene; Kite, a Gilead company
 
Paula Marlton
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; BeiGene; Gilead Sciences; Janssen; Jazz Pharmaceuticals; Roche
Speakers' Bureau - Abbvie
Travel, Accommodations, Expenses - Roche
 
John Francis Seymour
Honoraria - Abbvie; Acerta Pharma; Janssen; Roche; Sunesis Pharmaceuticals; Takeda
Consulting or Advisory Role - Abbvie; Acerta Pharma; AstraZeneca; BMS; Gilead Sciences; Janssen; MEI Pharma; MorphoSys; Roche; Sunesis Pharmaceuticals; Takeda
Speakers' Bureau - Abbvie; Roche
Research Funding - Abbvie; Celgene; Janssen; Roche
Expert Testimony - Roche
Travel, Accommodations, Expenses - Abbvie; Roche
 
Paolo Corradini
Honoraria - Abbvie; Amgen; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen; KiowaKirin; Kite, a Gilead company; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Daiichi Sankyo; Gilead Sciences; Incyte; Janssen; Jazz Pharmaceuticals; KiowaKirin; Kite/Gilead; Novartis; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Abbvie; Celgene; Gilead Sciences; Janssen; Kite, a Gilead company; Novartis; Takeda
 
Annalia Molinari
No Relationships to Disclose
 
Giuseppe Gritti
Consulting or Advisory Role - Autolus; Gilead Sciences; IQvia; Takeda
Speakers' Bureau - Amgen; Roche
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen; Roche
 
Robert Emmons
No Relationships to Disclose
 
Jamie Hirata
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Lisa Musick
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Sourish Saha
Employment - Genentech
 
Brandon Croft
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Christopher Flowers
Consulting or Advisory Role - Abbvie; Bayer; BeiGene; Celgene; Denovo Biopharma; Genentech/Roche; Gilead Sciences; Karyopharm Therapeutics; Pharmacyclics/Janssen; Spectrum Pharmaceuticals
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Alimera Sciences (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Millennium (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst); Xencor (Inst)